Impairment of proteasome structure and function in aging

International Journal of Biochemistry and Cell Biology

Volumn 34, Issue 11, 2002, Pages 1461-1474

  Carrard, Géraldine ^a   Bulteau, Anne Laure ^a   Petropoulos, Isabelle ^a   Friguet, Bertrand ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Aging; Damaged proteins degradation; Oxidation; Proteasome

Indexed keywords

CELL PROTEIN; PEPTIDASE; PROTEASOME; PROTEIN SUBUNIT;

CATALYSIS; CELL AGING; CELL DEGENERATION; CELL FUNCTION; CROSS LINKING; CYTOSOL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; MOLECULAR RECOGNITION; OXIDATION; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW;

AGING; ANIMALS; CYSTEINE ENDOPEPTIDASES; HUMANS; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; OXIDANTS; OXIDATION-REDUCTION; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS;

EID: 0036830343     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(02)00085-7     Document Type: Review

References (137)

1. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272:1997;2013-20316.
2. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;547-581.
3. H. Van Remmen, W.F. Ward, R.V. Sabia, A. Richardson, Gene expression and protein degradation, in: E.J. Masoro (Ed.), Handbook of Physiology - Aging, Oxford University Press, New York, 1995, pp. 171-234.
4. W.F. Ward, A. Richardson, Changes in protein turnover as a function of age and nutritional status, in: R.R. Watson (Ed.), CRC Handbook of Nutrition and Aging, CRC Press, Boca Raton, FL, 2000, pp. 251-257.
5. Stadtman E.R. Protein oxidation and aging. Science. 257:1992;1220-1224.
6. Jenner P. Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci. 24:2001;245-247.
7. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:1996;801-847.
8. Grune T., Reinheckel T., Davies K.J. Degradation of oxidized proteins in mammalian cell. FASEB J. 11:1997;526-534.
9. Voges D., Zwickl P., Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68:1999;1015-1068.
10. Lecker S.H., Solomon V., Mitch W.E., Goldberg A.L. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 129:1999;227S-237S.
11. Ciechanover A., Orian A., Schwartz A.L. The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J. Cell Biochem. Suppl. 34:2000;40-51.
12. Drexler H.G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia. 12:1998;845-859.
13. Chang Y.C., Lee Y.S., Tejima T., Tanaka K., Omura S., Heintz N.H., Mitsui Y., Magae J. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell Growth Differ. 9:1998;79-84.
14. King R.W., Deshaies R.J., Peters J.M., Kirschner M.W. How proteolysis drives the cell cycle. Science. 274:1996;1652-1659.
15. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:1998;28-35.
16. Gillette T.G., Huang W., Russell S.J., Reed S.H., Johnston S.A., Friedberg E.C. The 19S complex of the proteasome regulates nucleotide excision repair in yeast. Genes Dev. 15:2001;1528-1539.
17. Pajonk F., McBride W.H. The proteasome in cancer biology and treatment. Radiat. Res. 156:2001;447-459.
18. Tanaka K., Ii K., Ichihara A., Waxman L., Goldberg A.L. A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution. J. Biol. Chem. 261:1986;15197-15203.
19. Bochtler M., Ditzel L., Groll M., Hartmann C., Huber R. The proteasome. Annu. Rev. Biophys. Biomol. Struct. 28:1999;295-317.
20. Kruger E., Kloetzel P.M., Enenkel C. 20S proteasome biogenesis. Biochimie. 83:2001;289-293.
21. Kopp F., Steiner R., Dahlmann B., Kuehn L., Reinauer H. Size and shape of the multi-catalytic proteinase from rat skeletal muscle. Biochim. Biophys. Acta. 872:1986;253-260.
22. Hegerl R., Pfeifer G., Puhler G., Dahlmann B., Baumeister W. The three-dimensional structure of proteasomes from Thermoplasma acidophilum as determined by electron microscopy using random conical tilting. FEBS Lett. 283:1991;117-121.
23. Lowe J., Stock D., Jap B., Zwickl P., Baumeister W., Huber R. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science. 268:1995;533-539.
24. Yoshimura T., Kameyama K., Takagi T., Ikai A., Tokunaga F., Koide T., Tanahashi N., Tamura T., Cejka Z., Baumeister W. Molecular characterization of the 26S proteasome complex from rat liver. J. Struct. Biol. 111:1993;200-211.
25. Zwickl P., Grziwa A., Puhler G., Dahlmann B., Lottspeich F., Baumeister W. Primary structure of the Thermoplasma proteasome and its implications for the structure, function, and evolution of the multi-catalytic proteinase. Biochemistry. 31:1992;964-972.
26. Coux O., Nothwang H.G., Silva Pereira I., Recillas Targa F., Bey F., Scherrer K. Phylogenic relationships of the amino acid sequences of prosome (proteasome, MCP) subunits. Mol. Gen. Genet. 245:1994;769-780.
27. Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H.D., Huber R. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature. 386:1997;463-471.
28. Ramos P.C., Hockendorff J., Johnson E.S., Varshavsky A., Dohmen R.J. Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly. Cell. 92:1998;489-499.
29. Arendt C.S., Hochstrasser M. Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly. EMBO J. 18:1999;3575-3585.
30. Gaczynska M., Osmulski P.A., Ward W.F. Caretaker or undertaker? The role of the proteasome in aging. Mech. Ageing Dev. 122:2001;235-254.
31. Brannigan J.A., Dodson G., Duggleby H.J., Moody P.C., Smith J.L., Tomchick D.R., Murzin A.G. A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature. 378:1995;416-419.
32. Seemuller E., Lupas A., Stock D., Lowe J., Huber R., Baumeister W. Proteasome from Thermoplasma acidophilum: a threonine protease. Science. 268:1995;579-582.
33. Seemuller E., Lupas A., Baumeister W. Autocatalytic processing of the 20S proteasome. Nature. 382:1996;468-471.
34. Chen P., Hochstrasser M. Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell. 86:1996;961-972.
35. Kisselev A.F., Akopian T.N., Castillo V., Goldberg A.L. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol. Cell. 4:1999;395-402.
36. Orlowski M., Cardozo C., Michaud C. Evidence for the presence of five distinct proteolytic components in the pituitary multi-catalytic proteinase complex: properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry. 32:1993;1563-1572.
37. Tomkinson B. Tripeptidyl peptidases: enzymes that count. Trends Biochem. Sci. 24:1999;355-359.
38. Lee D.H., Goldberg A.L. Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J. Biol. Chem. 271:1996;27280-27284.
39. Craiu A., Gaczynska M., Akopian T., Gramm C.F., Fenteany G., Goldberg A.L., Rock K.L. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272:1997;13437-13445.
40. Meng L., Mohan R., Kwok B.H., Elofsson M., Sin N., Crews C.M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10403-10408.
41. Dick L.R., Cruikshank A.A., Grenier L., Melandri F.D., Nunes S.L., Stein R.L. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin β-lactone. J. Biol. Chem. 271:1996;7273-7276.
42. Fenteany G., Standaert R.F., Lane W.S., Choi S., Corey E.J., Schreiber S.L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:1995;726-731.
43. Stein R.L., Melandri F., Dick L. Kinetic characterization of the chymotryptic activity of the 20S proteasome. Biochemistry. 35:1996;3899-3908.
44. Ostrowska H., Wojcik C., Omura S., Worowski K. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme. Biochem. Biophys. Res. Commun. 234:1997;729-732.
45. Geier E., Pfeifer G., Wilm M., Lucchiari-Hartz M., Baumeister W., Eichmann K., Niedermann G. A giant protease with potential to substitute for some functions of the proteasome. Science. 283:1999;978-981.
46. Kroll M., Arenzana-Seisdedos F., Bachelerie F., Thomas D., Friguet B., Conconi M. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem. Biol. 6:1999;689-698.
47. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:1994;761-771.
48. Read M.A., Neish A.S., Luscinskas F.W., Palombella V.J., Maniatis T., Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 2:1995;493-506.
49. Mellgren R.L. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of μ-calpain and the 20S proteasome. J. Biol. Chem. 272:1997;29899-29903.
50. Adams J., Behnke M., Chen S., Cruickshank A.A., Dick L.R., Grenier L., Klunder J.M., Ma Y.T., Plamondon L., Stein R.L. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg. Med. Chem. Lett. 8:1998;333-338.
51. Gardner R.C., Assinder S.J., Christie G., Mason G.G., Markwell R., Wadsworth H., McLaughlin M., King R., Chabot-Fletcher M.C., Breton J.J., Allsop D., Rivett A.J. Characterization of peptidyl boronic acid inhibitors of mammalian 20S and 26S proteasomes and their inhibition of proteasomes in cultured cells. Biochem. J. 3462(Part 2):2000;447-454.
52. Bogyo M., McMaster J.S., Gaczynska M., Tortorella D., Goldberg A.L., Ploegh H. Covalent modification of the active site threonine of proteasomal β subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6629-6634.
53. Kisselev A.F., Goldberg A.L. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 8:2001;739-758.
54. Ma C.P., Slaughter C.A., DeMartino G.N. Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J. Biol. Chem. 267:1992;10515-10523.
55. Groll M., Bajorek M., Kohler A., Moroder L., Rubin D.M., Huber R., Glickman M.H., Finley D. A gated channel into the proteasome core particle. Nat. Struct. Biol. 7:2000;1062-1067.
56. Kohler A., Cascio P., Leggett D.S., Woo K.M., Goldberg A.L., Finley D. The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol. Cell. 7:2001;1143-1152.
57. Whitby F.G., Masters E.I., Kramer L., Knowlton J.R., Yao Y., Wang C.C., Hill C.P. Structural basis for the activation of 20S proteasomes by 11S regulators. Nature. 408:2000;115-120.
58. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67:1998;425-479.
59. Braun B.C., Glickman M., Kraft R., Dahlmann B., Kloetzel P.M., Finley D., Schmidt M. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat. Cell Biol. 1:1999;221-226.
60. Glickman M.H., Rubin D.M., Fu H., Larsen C.N., Coux O., Wefes I., Pfeifer G., Cjeka Z., Vierstra R., Baumeister W., Fried V., Finley D. Functional analysis of the proteasome regulatory particle. Mol. Biol. Rep. 26:1999;21-28.
61. Kloetzel P.M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2:2001;179-187.
62. Deveraux Q., Ustrell V., Pickart C., Rechsteiner M. A 26S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 269:1994;7059-7061.
63. van Nocker S., Sadis S., Rubin D.M., Glickman M., Fu H., Coux O., Wefes I., Finley D., Vierstra R.D. The multi-ubiquitin-chain-binding protein Mcb1 is a component of the 26S proteasome in Saccharomyces cerevisiae and plays a non-essential, substrate-specific role in protein turnover. Mol. Cell. Biol. 16:1996;6020-6028.
64. Chu-Ping M., Slaughter C.A., DeMartino G.N. Purification and characterization of a protein inhibitor of the 20S proteasome (macropain). Biochim. Biophys. Acta. 1119:1992;303-311.
65. Dubiel W., Pratt G., Ferrell K., Rechsteiner M. Purification of an 11S regulator of the multi-catalytic protease. J. Biol. Chem. 267:1992;22369-22377.
66. Mott J.D., Pramanik B.C., Moomaw C.R., Afendis S.J., DeMartino G.N., Slaughter C.A. PA28, an activator of the 20S proteasome, is composed of two non-identical but homologous subunits. J. Biol. Chem. 269:1994;31466-31471.
67. Ahn J.Y., Tanahashi N., Akiyama K., Hisamatsu H., Noda C., Tanaka K., Chung C.H., Shibmara N., Willy P.J., Mott J.D. Primary structures of two homologous subunits of PA28, a γ-interferon-inducible protein activator of the 20S proteasome. FEBS Lett. 366:1995;37-42.
68. Ma C.P., Willy P.J., Slaughter C.A., DeMartino G.N. PA28, an activator of the 20S proteasome, is inactivated by proteolytic modification at its carboxyl-terminus. J. Biol. Chem. 268:1993;22514-22519.
69. -/- mice. Science. 286:1999;2162-2165.
70. Rechsteiner M., Realini C., Ustrell V. The proteasome activator 11S REG (PA28) and class I antigen presentation. Biochem. J. 3451(Pt.):2000;1-15.
71. Tanahashi N., Murakami Y., Minami Y., Shimbara N., Hendil K.B., Tanaka K. Hybrid proteasomes: induction by γ-interferon and contribution to ATP-dependent proteolysis. J. Biol. Chem. 275:2000;14336-14345.
72. Akiyama K., Kagawa S., Tamura T., Shimbara N., Takashina M., Kristensen P., Hendil K.B., Tanaka K., Ichihara A. Replacement of proteasome subunits X and Y by Lmp7 and Lmp2 induced by γ-interferon for acquirement of the functional diversity responsible for antigen processing. FEBS Lett. 343:1994;85-88.
73. Belich M.P., Trowsdale J. Proteasome and class I antigen processing and presentation. Mol. Biol. Rep. 21:1995;53-56.
74. Hisamatsu H., Shimbara N., Saito Y., Kristensen P., Hendil K.B., Fujiwara T., Takahashi E., Tanahashi N., Tamura T., Ichihara A., Tanaka K. Newly identified pair of proteasomal subunits regulated reciprocally by γ-interferon. J. Exp. Med. 183:1996;1807-1816.
75. Gaczynska M., Rock K.L., Goldberg A.L. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature. 365:1993;26426-26427.
76. Weissman A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol. 2:2001;169-178.
77. Davies K.J. Protein damage and degradation by oxygen radicals. I. General aspects. J. Biol. Chem. 262:1987;9895-9901.
78. Nordberg J., Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31:2001;1287-1312.
79. Schallreuter K.U., Wood J.M. Thioredoxin reductase - its role in epidermal redox status. J. Photochem. Photobiol. B. 64:2001;179-184.
80. Moskovitz J., Yim M.B., Chock P.B. Free radicals and disease. Arch. Biochem. Biophys. 397:2002;354-359.
81. Fisher M.T., Stadtman E.R. Oxidative modification of Escherichia coli glutamine synthetase: decreases in the thermodynamic stability of protein structure and specific changes in the active site conformation. J. Biol. Chem. 267:1992;1872-1880.
82. Friguet B., Szweda L.I., Stadtman E.R. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multi-catalytic protease. Arch. Biochem. Biophys. 311:1994;168-173.
83. Ferrington D.A., Sun H., Murray K.K., Costa J., Williams T.D., Bigelow D.J., Squier T.C. Selective degradation of oxidized calmodulin by the 20S proteasome. J. Biol. Chem. 276:2001;937-943.
84. Stadtman E.R., Levine R.L. Protein oxidation. Ann. N. Y. Acad. Sci. 899:2000;191-208.
85. Venkatraman J., Aggarwal K., Balaram P. Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement. Chem. Biol. 8:2001;611-625.
86. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70:1994;138-151.
87. Sell D.R., Monnier V.M. End-stage renal disease and diabetes catalyze the formation of a pentose-derived cross-link from aging human collagen. J. Clin. Invest. 85:1990;380-384.
88. Nagaraj R.H., Sell D.R., Prabhakaram M., Ortwerth B.J., Monnier V.M. High correlation between pentosidine protein cross-links and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10257-10261.
89. Gracy R.W., Yuksel K.U., Chapman M.L., Dimitrijevich S.D. Isoprotein changes in aging: biochemical basis and physiological consequences. Prog. Clin. Biol. Res. 344:1990;787-817.
90. Hipkiss A.R. On the struggle between chemistry and biology during aging - implications for DNA repair, apoptosis and proteolysis, and a novel route of intervention. Biogerontology. 2:2001;173-178.
91. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233:1994;346-357.
92. Petropoulos I., Conconi M., Wang X., Hoenel B., Bregegere F., Milner Y., Friguet B. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J. Gerontol. A Biol. Sci. Med. Sci. 55:2000;B220-B227.
93. Levine R.L., Stadtman E.R. Oxidative modification of proteins during aging. Exp. Gerontol. 36:2001;1495-1502.
94. Carney J.M., Smith C.D., Carney A.M., Butterfield D.A. Aging- and oxygen-induced modifications in brain biochemistry and behavior. Ann. N. Y. Acad. Sci. 738:1994;44-53.
95. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., Von Zglinicki T., Davies K.J. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 14:2000;1490-1498.
96. Boscia F., Grattagliano I., Vendemiale G., Micelli-Ferrari T., Altomare E. Protein oxidation and lens opacity in humans. Invest. Ophthalmol. Vis. Sci. 41:2000;2461-2465.
97. Keller J.N., Hanni K.B., Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75:2000;436-439.
98. Yan L.J., Levine R.L., Sohal R.S. Oxidative damage during aging targets mitochondrial aconitase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;11168-11172.
99. Yan L.J., Sohal R.S. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc. Natl. Acad. Sci. U.S.A. 95:1998;12896-12901.
100. Shang F., Taylor A. Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem. J. 307:1995;297-303.
101. Shang F., Nowell T.R. Jr., Taylor A. Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. Exp. Eye Res. 73:2001;229-238.
102. Okada K., Wangpoengtrakul C., Osawa T., Toyokuni S., Tanaka K., Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress: identification of proteasomes as target molecules. J. Biol. Chem. 274:1999;23787-23793.
103. Bulteau A.-L., Verbeke P., Petropoulos I., Chaffotte A.F., Friguet B. Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20S proteasome degradation in vitro. J. Biol. Chem. 14:2001;14.
104. Davies K.J. Degradation of oxidized proteins by the 20S proteasome. Biochimie. 83:2001;301-310.
105. Hershko A., Ciechanover A., Varshavsky A. Basic medical research award: the ubiquitin system. Nat. Med. 6:2000;1073-1081.
106. Pickart C.M. Ubiquitin in chains. Trends Biochem. Sci. 25:2000;544-548.
107. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:2001;503-533.
108. Shibatani T., Nazir M., Ward W.F. Alterations of rat liver 20S proteasome activities by age and food restriction. J. Gerontol. Biol. Sci. 51:1996;316-322.
109. Conconi M., Szweda L.I., Levine R.L., Stadtman E.R., Friguet B. Age-related decline of rat liver multi-catalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch. Biochem. Biophys. 331:1996;232-240.
110. Anselmi B., Conconi M., Veyrat-Durebex C., Turlin E., Biville F., Alliot J., Friguet B. Dietary self-selection can compensate an age-related decrease of rat liver 20S proteasome activity observed with standard diet. J. Gerontol. A Biol. Sci. Med. Sci. 53:1998;B173-B179.
111. Ponnappan U., Zhong M., Trebilcock G.U. Decreased proteasome-mediated degradation in T cells from the elderly: a role in immune senescence. Cell. Immunol. 192:1999;167-174.
112. Keller J.N., Hanni K.B., Markesbery W.R. Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech. Ageing Dev. 113:2000;61-70.
113. Agarwal S., Sohal R.S. Aging and proteolysis of oxidized proteins. Arch. Biochem. Biophys. 309:1994;24-28.
114. Ding Q., Keller J.N. Proteasomes and proteasome inhibition in the central nervous system. Free Radic. Biol. Med. 31:2001;574-584.
115. Cuervo A.M., Dice J.F. When lysosomes get old. Exp. Gerontol. 35:2000;119-131.
116. Goto S., Takahashi R., Araki S., Nakamoto H. Dietary restriction initiated in late adulthood can reverse age-related alterations of protein and protein metabolism. Ann. N. Y. Acad. Sci. 959:2002;50-56.
117. Ly D.H., Lockhart D.J., Lerner R.A., Schultz P.G. Mitotic misregulation and human aging. Science. 287:2000;2486-2492.
118. Lee C.K., Klopp R.G., Weindruch R., Prolla T.A. Gene expression profile of aging and its retardation by caloric restriction. Science. 285:1999;1390-1393.
119. Bulteau A.-L., Szweda L.I., Friguet B. Age-dependent declines in proteasome activity in the heart. Arch. Biochem. Biophys. 397:2002;298-304.
120. Merker K., Sitte N., Grune T. Hydrogen peroxide-mediated protein oxidation in young and old human MRC5 fibroblasts. Arch. Biochem. Biophys. 375:2000;50-54.
121. Chondrogianni N., Petropoulos I., Franceschi C., Friguet B., Gonos E.S. Fibroblast cultures from healthy centenarians have an active proteasome (in process citation). Exp. Gerontol. 35:2000;721-728.
122. Conconi M., Petropoulos I., Emod I., Turlin E., Biville F., Friguet B. Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90. Biochem. J. 333:1998;407-415.
123. Reinheckel T., Sitte N., Ullrich O., Kuckelkorn U., Davies K.J., Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem. J. 335:1998;637-642.
124. Glockzin S., von Knethen A., Scheffner M., Brune B. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J. Biol. Chem. 274:1999;19581-19586.
125. Conconi M., Friguet B. Proteasome inactivation upon aging and on oxidation-effect of HSP 90. Mol. Biol. Rep. 24:1997;45-50.
126. Keller J.N., Huang F.F., Zhu T., Yu T., Ho Y.S., Kindy M.S. Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J. Cereb. Blood Flow Metab. 20:2000;1467-1473.
127. Bulteau A.-L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., Szweda L.I. Oxidative modification and inactivation of the proteasome during coronary occlusion-reperfusion. J. Biol. Chem. 25:2001;25.
128. Friguet B., Bulteau A.-L., Chondrogianni N., Conconi M., Petropoulos I. Protein degradation by the proteasome and its implications in aging. Ann. N. Y. Acad. Sci. 908:2000;143-154.
129. Hayashi T., Goto S. Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats. Mech. Ageing Dev. 102:1998;55-66.
130. Bulteau A.-L., Petropoulos I., Friguet B. Age-related alterations of proteasome structure and function in aging epidermis. Exp. Gerontol. 35:2000;767-777.
131. Friguet B., Szweda L.I. Inhibition of the multi-catalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 405:1997;21-25.
132. Friguet B., Stadtman E.R., Szweda L.I. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal: formation of cross-linked protein that inhibits the multi-catalytic protease. J. Biol. Chem. 269:1994;21639-21643.
133. Musti A.M., Treier M., Bohmann D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science. 275:1997;400-402.
134. 2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26S proteasomes without ubiquitination. J. Biol. Chem. 275:2000;20295-20301.
135. Krappmann D., Wulczyn F.G., Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo. EMBO J. 15:1996;6716-6726.
136. Murakami Y., Matsufuji S., Kameji T., Hayashi S., Igarashi K., Tamura T., Tanaka K., Ichihara A. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature. 360:1992;597-599.
137. Gross-Mesilaty S., Hargrove J.L., Ciechanover A. Degradation of tyrosine aminotransferase (TAT) via the ubiquitin-proteasome pathway. FEBS Lett. 405:1997;175-180.